Wave Life Sciences
58 hedge funds and large institutions have $446M invested in Wave Life Sciences in 2017 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 24 increasing their positions, 12 reducing their positions, and 6 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 12
33% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 6
24% more capital invested
Capital invested by funds: $359M → $446M (+$86.5M)
4.14% more ownership
Funds ownership: 69.68% → 73.82% (+4.1%)
4% more funds holding
Funds holding: 56 → 58 (+2)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$12.6M |
| 2 |
EC
EcoR1 Capital
San Francisco,
California
|
+$11.3M |
| 3 |
BM
Bridger Management
New York
|
+$5.85M |
| 4 |
JP Morgan Chase
New York
|
+$2.37M |
| 5 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$1.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$3.35M |
| 2 |
FCMI
Foresite Capital Management III
Larkspur,
California
|
-$2.83M |
| 3 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$2.33M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.31M |
| 5 |
Jennison Associates
New York
|
-$1.4M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Legal & General Group
London,
United Kingdom
| $83K | +$13K | +645 | +20% |
|
52
UBS Group
Zurich,
Switzerland
| $74K | +$8.34K | +415 | +14% |
|
|
TRCT
53
Tower Research Capital (TRC)
New York
| $68K | +$48.9K | +2,433 | +343% |
|
54
Bank of America
Charlotte,
North Carolina
| $38K | +$31.4K | +1,562 | +822% |
|
55
Royal Bank of Canada
Toronto,
Ontario, Canada
| $32K | +$18.3K | +911 | +171% |
|
56
BNP Paribas Financial Markets
Paris,
France
| $26.3K | -$1.55K | -77 | -6% |
|
|
AIP
57
Ameritas Investment Partners
Lincoln,
Nebraska
| $24K | – | – | – |
|
|
PSC
58
Prentiss Smith & Co
Brattleboro,
Vermont
| $11K | – | – | – |
|
|
OM
59
Opaleye Management
Boston,
Massachusetts
| – | -$2.33M | -125,000 | Closed |
|
|
60
Jennison Associates
New York
| – | -$1.4M | -75,435 | Closed |
|
61
Balyasny Asset Management
Chicago,
Illinois
| – | -$911K | -49,000 | Closed |
|
|
VIA
62
Vident Investment Advisory
Alpharetta,
Georgia
| – | -$261K | -14,057 | Closed |
|
|
SO
63
STRS Ohio
Columbus,
Ohio
| – | -$221K | -11,900 | Closed |
|
64
Citigroup
New York
| – | -$1K | -80 | Closed |
|
WVE Hedge Fund Activity: Q3 2017 in Review
58 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Wave Life Sciences (WVE) for Q3 2017, worth a combined $446M — up 24% from $359M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new WVE positions and 6 closed out — a net gain of 2 holders — while 24 added to existing stakes and 12 trimmed.
The largest buyer was Point72 Asset Management, opening a new position worth an estimated $12.6M. The largest seller was Deerfield Management, cutting an estimated $3.35M.
- 58 institutional investors held Wave Life Sciences (WVE) as of Q3 2017, up from 56 in Q2 2017.
- Funds reported $446M of Wave Life Sciences stock for Q3 2017, up 24% quarter-over-quarter.
- 8 funds opened new Wave Life Sciences positions in Q3 2017 and 6 closed out, a net change of +2 holders.
- The largest Wave Life Sciences buyer in Q3 2017 was Point72 Asset Management, an estimated $12.6M added.
- The largest Wave Life Sciences seller in Q3 2017 was Deerfield Management, an estimated $3.35M sold.
Based on aggregated 13F filings for Q3 2017.